Literature DB >> 12816977

Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells.

Anthony M Byers1, Christopher C Kemball, Janice M Moser, Aron E Lukacher.   

Abstract

For viruses that establish persistent infection, continuous immunosurveillance by effector-competent antiviral CD8(+) T cells is likely essential for limiting viral replication. Although it is well documented that virus-specific memory CD8(+) T cells synthesize cytokines after short term in vitro stimulation, there is limited evidence that these T cells exhibit cytotoxicity, the dominant antiviral effector function. Here, we show that antiviral CD8(+) T cells in mice acutely infected by polyoma virus, a persistent mouse pathogen, specifically eliminate viral peptide-pulsed donor spleen cells within minutes after adoptive transfer and do so via a perforin-dependent mechanism. Antiviral memory CD8(+) T cells were similarly capable of rapidly mobilizing potent Ag-specific cytotoxic activity in vivo. These findings strongly support the concept that a cytotoxic effector-memory CD8(+) T cell population operates in vivo to control this persistent viral infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12816977     DOI: 10.4049/jimmunol.171.1.17

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  Trp2 peptide vaccine adjuvanted with (R)-DOTAP inhibits tumor growth in an advanced melanoma model.

Authors:  Elizabeth A Vasievich; Srinivas Ramishetti; Yuan Zhang; Leaf Huang
Journal:  Mol Pharm       Date:  2011-12-28       Impact factor: 4.939

Review 2.  Reflections on CD8 T-cell activation and memory.

Authors:  David Masopust; Rafi Ahmed
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 3.  Memory CD8 T-cell differentiation during viral infection.

Authors:  E John Wherry; Rafi Ahmed
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

4.  Cell-based flow cytometry assay to measure cytotoxic activity.

Authors:  Alessandra Noto; Pearline Ngauv; Lydie Trautmann
Journal:  J Vis Exp       Date:  2013-12-17       Impact factor: 1.355

5.  Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine.

Authors:  Elizabeth A Vasievich; Weihsu Chen; Leaf Huang
Journal:  Cancer Immunol Immunother       Date:  2011-01-26       Impact factor: 6.968

6.  Neoantigen Expression in Steady-State Langerhans Cells Induces CTL Tolerance.

Authors:  Helen Strandt; Douglas Florindo Pinheiro; Daniel H Kaplan; Dagmar Wirth; Iris Karina Gratz; Peter Hammerl; Josef Thalhamer; Angelika Stoecklinger
Journal:  J Immunol       Date:  2017-07-24       Impact factor: 5.422

7.  A reduced antigen load in vivo, rather than weak inflammation, causes a substantial delay in CD8+ T cell priming against Mycobacterium bovis (bacillus Calmette-Guérin).

Authors:  Marsha S Russell; Monica Iskandar; Oksana L Mykytczuk; John H E Nash; Lakshmi Krishnan; Subash Sad
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

8.  Estimating in vivo death rates of targets due to CD8 T-cell-mediated killing.

Authors:  Vitaly V Ganusov; Rob J De Boer
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

9.  The effects of salt on the physicochemical properties and immunogenicity of protein based vaccine formulated in cationic liposome.

Authors:  Weili Yan; Leaf Huang
Journal:  Int J Pharm       Date:  2008-10-15       Impact factor: 5.875

Review 10.  Memory T-cell-specific therapeutics in organ transplantation.

Authors:  Andrew J Page; Mandy L Ford; Allan D Kirk
Journal:  Curr Opin Organ Transplant       Date:  2009-12       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.